Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
Glenmark receives Czech GMP certificate for Indian facility
Glenmark Pharmaceuticals' Baddi manufacturing unit in the India has fulfilled GMP recommendation in line with the WHO
Pharmaceutical
Horizon signs license agreement with Glenmark for CHO cell line
gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line has been licenced to be incorporated into the biomanufacturing process
Manufacturing
Glenmark chooses Novartis for respiratory products
The Seebri, Onbrize and Ultibro products are indicated for COPD symptoms and will be manufactured by Novartis for Glenmark's Brazilian subsidiary
Logistics
Glenmark Pharmaceuticals awards UK supply chain to Yusen Logistics
Yusen Logistics, the award-winning pharmaceutical global logistics specialist, has been awarded a major contract by India-based pharmaceutical manufacturer Glenmark Pharmaceuticals
Regulatory
Indian pricing authority to address overcharging by pharma companies
NPPA has decided to chase drug majors for defaulting on penalties that have been imposed for overcharging consumers for medicines
Pharmaceutical
Indian pharma firms develop niche portfolios
They aim to take advantage of generic growth in the US over the next two years
Pharmaceutical
Indian generic manufacturers aim to enter the Japanese market
The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Subscribe now